Welcome to LookChem.com Sign In|Join Free
  • or
4-chloro-5-[4-methoxy-3-(2-methoxyethoxy)phenyl]-nicotinonitrile is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

959972-28-2

Post Buying Request

959972-28-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

959972-28-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 959972-28-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,9,7 and 2 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 959972-28:
(8*9)+(7*5)+(6*9)+(5*9)+(4*7)+(3*2)+(2*2)+(1*8)=252
252 % 10 = 2
So 959972-28-2 is a valid CAS Registry Number.

959972-28-2Relevant academic research and scientific papers

Synthesis and PKCθ inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles

Dushin, Russell G.,Nittoli, Thomas,Ingalls, Charles,Boschelli, Diane H.,Cole, Derek C.,Wissner, Allan,Lee, Julie,Yang, Xiaoke,Morgan, Paul,Brennan, Agnes,Chaudhary, Divya

scheme or table, p. 2461 - 2463 (2009/12/25)

A series of 4-indolylamino-5-phenyl-3-pyridinecarbonitrile inhibitors of PKCθ were synthesized as potential anti-inflammatory agents. The effects of specific substitution on the 5-phenyl moiety and variations of the positional isomers of the 4-indolylamino substituent were explored. This study led to the discovery of compound 12d, which had an IC50 value of 18 nM for the inhibition of PKCθ.

Substituted Cyanopyridines as protein kinase inhibitors

-

Page/Page column 21, (2008/06/13)

The present teachings provide compounds of formula I and their pharmaceutically acceptable salts, hydrates, and esters, wherein R1, R2, and X are as defined herein. The present teachings also provide methods of making the compounds of formula I, and methods of treating autoimmune and inflammatory diseases by administering a therapeutically effective amount of a compound or compounds of formula I to a mammal including a human.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 959972-28-2